| Family: | Blackrock (iShares) |
| Name: | iShares US Pharmaceuticals ETF |
| Inception Date: | 1-May-2006 |
| Termination Date: | |
| Investment Objective: | The iShares Dow Jones U.S. Pharmaceuticals Index Fund seeks investment results that correspond generally to the price and yield performance before fees and expenses of the Dow Jones U.S. Select Pharmaceuticals Index. |
| Prospectus | |
| Top 10 Holdings | ||
| JOHNSON & JOHNSON | JNJ | 23.6171% |
| ELI LILLY | LLY | 21.1388% |
| MERCK & CO INC | MRK | 5.1511% |
| BRISTOL MYERS SQUIBB | BMY | 4.7116% |
| ROYALTY PHARMA PLC CLASS A | RPRX | 4.5060% |
| VIATRIS | VTRS | 4.5032% |
| PFIZER | PFE | 4.5010% |
| ZOETIS INC CLASS A | ZTS | 3.7447% |
| JAZZ PHARMACEUTICALS PLC | JAZZ | 3.4536% |
| ELANCO ANIMAL HEALTH | ELAN | 2.5638% |
| Top 10 Holdings Weight: | 77.9% |
| Number of Holdings: | 59 |
| Shares Outstanding: | 16,350,000 |
| Total Net Assets: | 1,672,114,560 |
| NAV: | 102.25 |
| Net Expense Ratio: | 0.37% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Pharmaceuticals |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
